Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

NKGen Biotech, Inc. NKGN

Full chart Compare
Set alert

Price alert · NKGN

All alert types
0.06 USD 0.00 (+0.00%)

At closeFeb 5, 2026, 4:00 PM EST

0.18 +0.12 +204.17%

After hours · Feb 5, 4:00 PM ET

0.02 Day range 0.02
0.001 52-week range 0.20
YTD
+20.00%
1 year
-79.09%

Financial health

Altman Z-Score

-15.77 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.4×
FY 2021: -9.0×FY 2022: -8.0×FY 2023: -0.5×FY 2024: -0.4×
FY 2021 5y median -4.2× FY 2024
P/S 0.0×
FY 2021: 488×FY 2022: 2772×FY 2023: 0.0×FY 2024: 0.0×
FY 2021 5y median 244× FY 2024
P/B 0.0×
FY 2021: -5.5×FY 2022: 137×FY 2023: -0.7×FY 2024: 0.0×
FY 2021 5y median -0.4× FY 2024
P/FCF -0.9×
FY 2021: -10.4×FY 2022: -9.4×FY 2023: -1.9×FY 2024: -0.9×
FY 2021 5y median -5.7× FY 2024
EV/EBITDA -0.5×
FY 2021: -12.5×FY 2022: -9.7×FY 2023: -0.8×FY 2024: -0.5×
FY 2021 5y median -5.2× FY 2024
EV/Sales 0.0×
FY 2021: 609×FY 2022: 2927×FY 2023: 0.0×FY 2024: 0.0×
FY 2021 5y median 305× FY 2024
FCF Yield -110.5%
FY 2021: -9.6%FY 2022: -10.6%FY 2023: -51.8%FY 2024: -110.5%
FY 2021 5y median -31.2% FY 2024

Profitability

Gross Margin 0.0%
FY 2021: 93.0%FY 2022: 76.6%FY 2023: 0.0%FY 2024: 0.0%
FY 2021 5y median 38.3% FY 2024
Operating Margin 0.0%
FY 2021: -5131.7%FY 2022: -31618.2%FY 2023: 0.0%FY 2024: 0.0%
FY 2021 5y median -2565.8% FY 2024
Net Margin 0.0%
FY 2021: -5461.3%FY 2022: -34745.5%FY 2023: 0.0%FY 2024: 0.0%
FY 2021 5y median -2730.6% FY 2024
ROE 0.0%
FY 2021: 61.1%FY 2022: -1711.7%FY 2023: 141.3%FY 2024: 0.0%
FY 2021 5y median 30.6% FY 2024
ROIC -112358.3%
FY 2021: -156.8%FY 2022: -178.7%FY 2023: 229.2%FY 2024: -112358.3%
FY 2021 5y median -167.8% FY 2024
ROA -184525.0%
FY 2021: -128.7%FY 2022: -163.8%FY 2023: -503.3%FY 2024: -184525.0%
FY 2021 5y median -333.6% FY 2024

Growth (YoY)

Revenue 0.0%
FY 2021: 0.0%FY 2022: -81.9%FY 2023: -100.0%FY 2024: 0.0%
FY 2021 FY 2024
Operating Income 9.3%
FY 2021: 0.0%FY 2022: -11.4%FY 2023: -22.2%FY 2024: 9.3%
FY 2021 FY 2024
EPS (diluted) 71.4%
FY 2021: 0.0%FY 2022: -15.7%FY 2023: -330.4%FY 2024: 71.4%
FY 2021 FY 2024
Free Cash Flow 5.1%
FY 2021: 0.0%FY 2022: -13.6%FY 2023: 3.2%FY 2024: 5.1%
FY 2021 FY 2024

Financial Health

Current Ratio 0.0×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2021 5y median 0.0× FY 2024
Quick Ratio 0.0×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2021 5y median 0.0× FY 2024
Debt / Equity 0.0×
FY 2021: -1.4×FY 2022: 7.7×FY 2023: -0.3×FY 2024: 0.0×
FY 2021 5y median -0.2× FY 2024
Net Debt / EBITDA 0.0×
FY 2021: -2.5×FY 2022: -0.5×FY 2023: -0.2×FY 2024: 0.0×
FY 2021 5y median -0.4× FY 2024
Interest Coverage -9.9×
FY 2021: -16.6×FY 2022: -10.6×FY 2023: -39.9×FY 2024: -9.9×
FY 2021 5y median -13.6× FY 2024

Dividends

Dividend Yield 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2021 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2021 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31